Literature DB >> 213043

A longitudinal study of the serological and virological status of 18 women infected with cytomegalovirus.

P D Griffiths, S Stagno, D W Reynolds, C A Alford.   

Abstract

18 women, of known seropositivity, have been followed for between 18 and 66 months (mean 50.2 months) for viral excretion and serological changes. CMV was isolated from 58/146 (39.7 per cent) cultures from various sites, mostly cervix. A total of 129 sera were obtained and each was titrated in the late antigen, early antigen and anti-complement immunofluorescence assays, as well as the complement fixation and microneutralisation tests. From 3 women virus was consistently re-isolated, from 3 others virus was never re-isolated and the remaining 12 women excreted virus intermittently during the period of study. No significant changes in antibody titres could be detected by any of the 5 serological assays in any woman during periods of viral excretion. This suggests that local reactivation of latent CMV infection is not associated with a demonstrable systemic antibody response. Inter-assay correlations were sought for each of the 10 possible combinations of pairs of tests. Significant correlations were found for most pairs of tests, with the notable exception fo those involving the early antigen test. This confirms that antibodies detected in this assay are distinct from those detected by the other 4 serological assays.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213043     DOI: 10.1007/bf01315403

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  20 in total

1.  Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus.

Authors:  N E Cremer; N J Schmidt; F Jensen; M Hoffman; L S Oshiro; E H Lennette
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

2.  Microculture plaque assay for human and simian cytomegaloviruses.

Authors:  S Chiba; R L Striker; M Benyesh-Melnick
Journal:  Appl Microbiol       Date:  1972-04

Review 3.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-22       Impact factor: 91.245

4.  Congenital cytomegalovirus infection in two siblings from consecutive pregnancies.

Authors:  J A Embil; R L Ozere; E V Haldane
Journal:  J Pediatr       Date:  1970-09       Impact factor: 4.406

5.  Immunologic response to cytomegalovirus infection in renal allograft recipients.

Authors:  J E Craighead
Journal:  Am J Epidemiol       Date:  1969-12       Impact factor: 4.897

6.  Inapparent congenital cytomegalovirus infection. Clinical and epidemiologic characteristics in early infancy.

Authors:  J G Starr; R D Bart; E Gold
Journal:  N Engl J Med       Date:  1970-05-07       Impact factor: 91.245

7.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

8.  Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections.

Authors:  S Stagno; D W Reynolds; A Tsiantos; D A Fuccillo; W Long; C A Alford
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

9.  Prospective study of cytomegalovirus infection in pregnancy.

Authors:  H Stern; S M Tucker
Journal:  Br Med J       Date:  1973-05-05

10.  Cytomegalovirus antibody production in renal transplant patients.

Authors:  J Nagington
Journal:  J Hyg (Lond)       Date:  1971-12
View more
  9 in total

Review 1.  Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection.

Authors:  Michael J Cannon; Terri B Hyde; D Scott Schmid
Journal:  Rev Med Virol       Date:  2011-06-15       Impact factor: 6.989

2.  Cytomegalovirus-specific cell-mediated immunity in lower-socioeconomic-class adolescent women with local cytomegalovirus infections.

Authors:  R G Faix; S E Zweig; J F Kummer; D Moore; D J Lang
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Antibody response against early antigens in Herpesviridae infections.

Authors:  M P Landini
Journal:  Eur J Epidemiol       Date:  1985-03       Impact factor: 8.082

4.  Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections.

Authors:  L Pereira; S Stagno; M Hoffman; J E Volanakis
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

5.  A comparison of cervical cytomegalovirus (CMV) excretion in gynaecological patients and post-partum women.

Authors:  W A Knowles; S D Gardner; H Fox
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Comparison of shell viral culture and serology for the diagnosis of human cytomegalovirus infection in neonates and immunocompromised subjects.

Authors:  B Weber; A Hamann; B Ritt; H Rabenau; W Braun; H W Doerr
Journal:  Clin Investig       Date:  1992-06

7.  Persistence of high titre antibodies to the early antigens of cytomegalovirus in pregnant women.

Authors:  P D Griffiths; K J Buie; R B Heath
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  Differences in cognitive functions between cytomegalovirus-infected and cytomegalovirus-free university students: a case control study.

Authors:  Veronika Chvátalová; Blanka Šebánková; Hana Hrbáčková; Petr Tureček; Jaroslav Flegr
Journal:  Sci Rep       Date:  2018-03-28       Impact factor: 4.379

9.  New approach and new permutation tests with R programs for analyses of false-negative-contaminated data in medicine and biology.

Authors:  Jaroslav Flegr; Petr Tureček
Journal:  Biol Open       Date:  2020-01-23       Impact factor: 2.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.